CNBS
Amplify Seymour Cannabis ETF
Price Chart
Latest Quote
$23.63
| Previous Close | $23.25 |
| Open | $23.60 |
| Day High | $23.63 |
| Day Low | $23.42 |
| Volume | 896 |
Fund Information
| Net Assets | $71.59M |
| Expense Ratio | 0.76% |
| Category | Miscellaneous Sector |
| Fund Family | Amplify ETFs |
| Net Asset Value | $23.26 |
| Premium/Discount | 1.57% |
| P/E Ratio | 17.74 |
| Exchange | PCX |
📊 ETF Analysis
Company Data
Financial Ratios
Returns & Margins
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
Analyst Data
Technical Indicators
| SMA20 | $24.33 |
| SMA50 | $26.96 |
| SMA200 | $26.34 |
| RSI | 35.22 |
| ATR | 0.7526 |
| Rel Volume | 0.15 |
Performance History
| Week | +1.33% |
| Month | -19.80% |
| Quarter | -1.02% |
| 6 Months | -19.00% |
| YTD | -18.39% |
| Year | -19.50% |
| 3 Years | -28.46% |
| 5 Years | -84.55% |
| 10 Years | -87.95% |
ETF Scoring Not Available
Exchange-traded funds (ETFs) are not scored using our fundamental analysis metrics, as they represent baskets of securities rather than individual companies.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-10-27 | $23.63 | 896 |
| 2026-10-26 | $23.25 | 1,800 |
| 2026-10-23 | $22.92 | 2,100 |
| 2026-10-22 | $23.58 | 2,300 |
| 2026-10-21 | $23.88 | 8,500 |
| 2026-10-20 | $23.32 | 1,300 |
| 2026-10-19 | $22.49 | 2,300 |
| 2026-10-16 | $22.75 | 4,700 |
| 2026-10-15 | $23.73 | 3,300 |
| 2026-10-14 | $23.59 | 4,800 |
| 2026-10-13 | $23.85 | 3,900 |
| 2026-10-12 | $24.48 | 14,900 |
| 2026-10-09 | $24.97 | 1,900 |
| 2026-10-08 | $24.81 | 4,100 |
| 2026-10-07 | $25.65 | 7,600 |
| 2026-10-06 | $25.71 | 3,900 |
| 2026-10-05 | $25.53 | 6,400 |
| 2026-10-02 | $26.13 | 3,900 |
| 2026-10-01 | $26.28 | 2,700 |
| 2026-09-30 | $26.13 | 38,500 |
| 2026-09-29 | $29.25 | 3,700 |
| 2026-09-28 | $29.46 | 3,900 |
About Amplify Seymour Cannabis ETF
Under normal market conditions, the fund seeks to achieve its investment objective by investing in the securities of U.S. companies engaged in cannabis and hemp-related activities selected by the fund’s investment adviser, Amplify Investments LL. Pursuant to this strategy, it will invest at least 80% of its net assets (plus borrowings for investment purposes) in the securities of U.S. companies that derive 50% or more of their revenue from the cannabis and hemp ecosystem and in derivatives that have economic characteristics similar to such securities. The fund is non-diversified.